XBRANE · Xbrane Biopharma AB · Short Interest
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Net short positions in Xbrane Biopharma AB disclosed to the market regulator. Holders must report positions above the regulator's threshold, so these are disclosed positions, not total short interest, and absence is not a zero position.
Disclosed net short positions · Germany · Federal Gazette (BaFin)
Recent individual disclosures for ISIN SE0026598583. Net short-position notifications published in the Federal Gazette, including historised ones; absence is not a zero position. Percentages refer to issued capital, not free float. These are not total short interest or a list of current positions. Public disclosures generally begin at 0.5% per holder. A disclosure below that threshold does not establish the holder's subsequent position.
| Position date | Holder | Issued capital | Published |
|---|---|---|---|
| 2025-12-08 | Citadel Securities (Europe) Limited | 0.44% | Not supplied |
| 2025-12-04 | Citadel Securities (Europe) Limited | 0.52% | Not supplied |
| 2025-11-27 | Citadel Securities (Europe) Limited | 0.69% | Not supplied |
| 2025-11-25 | Citadel Securities (Europe) Limited | 0.72% | Not supplied |
| 2025-11-20 | Citadel Securities (Europe) Limited | 0.84% | Not supplied |
| 2025-11-14 | Citadel Securities (Europe) Limited | 0.75% | Not supplied |
| 2025-11-12 | Citadel Securities (Europe) Limited | 0.69% | Not supplied |
| 2025-10-24 | Citadel Securities (Europe) Limited | 0.84% | Not supplied |
| 2025-10-23 | Citadel Securities (Europe) Limited | 0.59% | Not supplied |
Checked 2026-11-13 13:56 UTC.